Angiographically silent cystoid macular oedema secondary to paclitaxel therapy

CD Georgakopoulos, OE Makri, P Vasilakis… - Clinical and …, 2012 - Taylor & Francis
CD Georgakopoulos, OE Makri, P Vasilakis, A Exarchou
Clinical and Experimental Optometry, 2012Taylor & Francis
Bilateral macular oedema is an uncommon side‐effect of paclitaxel administration in
oncological patients. We report the case of a 64‐year‐old man who presented with
decreased visual acuity due to bilateral macular oedema after paclitaxel administration for
lung cancer. Optical coherence tomography scans of both eyes revealed cystoid macular
oedema. Fluorescein angiography demonstrated the unusual finding of the absence of
localised retinal capillary leakage. Ketorolac eye drops and acetazolamide tablets were …
Bilateral macular oedema is an uncommon side‐effect of paclitaxel administration in oncological patients. We report the case of a 64‐year‐old man who presented with decreased visual acuity due to bilateral macular oedema after paclitaxel administration for lung cancer. Optical coherence tomography scans of both eyes revealed cystoid macular oedema. Fluorescein angiography demonstrated the unusual finding of the absence of localised retinal capillary leakage. Ketorolac eye drops and acetazolamide tablets were prescribed and one month later the cystoid macular oedema resolved with subsequent improvement in visual acuity. This case illustrates the unusual presentation of cystoid macular oedema induced by paclitaxel.
Taylor & Francis Online
以上显示的是最相近的搜索结果。 查看全部搜索结果